IL18 and atherosclerosis: Indeed, recombinant IL-18 administration to Apoe−/− mice promoted atherosclerosis development in an IFNγ-dependent manner [26], while its neutralization by the natural inhibitor IL-18 binding protein (IL-18BP) [27] or genetic knockout of IL-18 significantly reduced disease progression [28].